Amphastar Pharm Joins Elite List Of Stocks With 95-Plus Composite Rating

KTRADelisted Stock  USD 6.30  0.14  2.17%   
About 61% of KTRA Old's investor base is looking to short. The analysis of current outlook of investing in KTRA Old suggests that many traders are alarmed regarding KTRA Old's prospects. The current market sentiment, together with KTRA Old's historical and current headlines, can help investors time the market. In addition, many technical investors use KTRA Old stock news signals to limit their universe of possible portfolio assets.
  
Amphastar Pharm saw its IBD SmartSelect Composite Rating jump to 96 Thursday, up from 94 the day before.

Read at investors.com
Investors Business Daily at Macroaxis
  

KTRA Old Fundamental Analysis

We analyze KTRA Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of KTRA Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of KTRA Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Per Share

Cash Per Share Comparative Analysis

KTRA Old is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

KTRA Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with KTRA Old stock to make a market-neutral strategy. Peer analysis of KTRA Old could also be used in its relative valuation, which is a method of valuing KTRA Old by comparing valuation metrics with similar companies.

Peers

KTRA Old Related Equities

SABSSAB Biotherapeutics   6.05   
0%
55.0%
LSTALisata Therapeutics   1.88   
0%
17.0%
MISTMilestone Pharmaceuticals   0.90   
8.0%
0%
BOLTBolt Biotherapeutics   1.72   
15.0%
0%
MCRBSeres Therapeutics   2.30   
21.0%
0%
SCPHScpharmaceuticals   3.93   
36.0%
0%
ONCYOncolytics Biotech   4.40   
40.0%
0%
SLRXSalarius Pharmaceuticals   4.68   
43.0%
0%
DMACDiaMedica Therapeutics   4.88   
45.0%
0%
FBRXForte Biosciences   6.40   
59.0%
0%
CLRBCellectar Biosciences   8.82   
81.0%
0%
GOVXGeoVax Labs   9.09   
84.0%
0%
TOVXTheriva Biologics   9.26   
85.0%
0%
DYAIDyadic International   10.82   
100.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in KTRA Stock

If you are still planning to invest in KTRA Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the KTRA Old's history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets